Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
Objective To investigate the relationship between serum miR-199a-5p and miR-378a-3p levels and the recurrence of infants with proliferative facial hemangioma relapsed after propranolol withdrawal in infants. Methods Ninety-three infants with proliferative facial hemangioma were selected, all of whom...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ae03ff196204d588a494b32a035243a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4ae03ff196204d588a494b32a035243a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4ae03ff196204d588a494b32a035243a2021-11-25T07:18:56ZRelationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal10.12016/j.issn.2096-1456.2022.02.0042096-1456https://doaj.org/article/4ae03ff196204d588a494b32a035243a2022-02-01T00:00:00Zhttp://www.kqjbfz.com/CN/10.12016/j.issn.2096-1456.2022.02.004https://doaj.org/toc/2096-1456Objective To investigate the relationship between serum miR-199a-5p and miR-378a-3p levels and the recurrence of infants with proliferative facial hemangioma relapsed after propranolol withdrawal in infants. Methods Ninety-three infants with proliferative facial hemangioma were selected, all of whom received propranolol treatment. The recurrence of the hemangioma after treatment was followed up, and the children were divided into a recurrence group (23 patients) and a nonrecurrence group (70 patients). Venous blood was collected before and after treatment, and the serum levels of miR-199a-5p and miR-378a-3p were detected by qRT-PCR, and the relationship between the serum levels of miR-199a-5p and miR-378a-3p and the recurrence of proliferative facial hemangioma relapsed after propranolol withdrawal in infants was analyzed. Results The serum expressions levels of miR-199a-5p and miR-378a-3p in non-relapsed group were increased after treatment compared with before treatment (P < 0.05), and there was no significant difference in the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group after treatment compared with before treatment (P > 0.05). After treatment, the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group were lower than those of the nonrecurrence group (P < 0.05). After treatment, the serum levels of miR-199a-5p and miR-378a-3p in patients with Ⅲ ~Ⅳ Norm grade hemangioma were higher than those in patients with Ⅰ~Ⅱ Norm grade hemangioma (P < 0.05). Logistic regression analysis showed that the low expression of miR-199a-5p, low expression of miR-378a-3p and tumor grade Ⅰ~Ⅱ after treatment were risk factors for the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants (P < 0.05). Conclusion Low serum levels of miR-199a-5p and miR-378a-3p are associated with the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants.GUO YanZHANG Kai FAN XuhuiLI LifengEditorial Department of Journal of Prevention and Treatment for Stomatological Diseasesarticlemicro ribonucleic acidmir-199a-5pmir-378a-3ppropranololinfanthemangiomarecurrenceendothelial cell proliferationMedicineRZH口腔疾病防治, Vol 30, Iss 2, Pp 97-102 (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
ZH |
topic |
micro ribonucleic acid mir-199a-5p mir-378a-3p propranolol infant hemangioma recurrence endothelial cell proliferation Medicine R |
spellingShingle |
micro ribonucleic acid mir-199a-5p mir-378a-3p propranolol infant hemangioma recurrence endothelial cell proliferation Medicine R GUO Yan ZHANG Kai FAN Xuhui LI Lifeng Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
description |
Objective To investigate the relationship between serum miR-199a-5p and miR-378a-3p levels and the recurrence of infants with proliferative facial hemangioma relapsed after propranolol withdrawal in infants. Methods Ninety-three infants with proliferative facial hemangioma were selected, all of whom received propranolol treatment. The recurrence of the hemangioma after treatment was followed up, and the children were divided into a recurrence group (23 patients) and a nonrecurrence group (70 patients). Venous blood was collected before and after treatment, and the serum levels of miR-199a-5p and miR-378a-3p were detected by qRT-PCR, and the relationship between the serum levels of miR-199a-5p and miR-378a-3p and the recurrence of proliferative facial hemangioma relapsed after propranolol withdrawal in infants was analyzed. Results The serum expressions levels of miR-199a-5p and miR-378a-3p in non-relapsed group were increased after treatment compared with before treatment (P < 0.05), and there was no significant difference in the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group after treatment compared with before treatment (P > 0.05). After treatment, the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group were lower than those of the nonrecurrence group (P < 0.05). After treatment, the serum levels of miR-199a-5p and miR-378a-3p in patients with Ⅲ ~Ⅳ Norm grade hemangioma were higher than those in patients with Ⅰ~Ⅱ Norm grade hemangioma (P < 0.05). Logistic regression analysis showed that the low expression of miR-199a-5p, low expression of miR-378a-3p and tumor grade Ⅰ~Ⅱ after treatment were risk factors for the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants (P < 0.05). Conclusion Low serum levels of miR-199a-5p and miR-378a-3p are associated with the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants. |
format |
article |
author |
GUO Yan ZHANG Kai FAN Xuhui LI Lifeng |
author_facet |
GUO Yan ZHANG Kai FAN Xuhui LI Lifeng |
author_sort |
GUO Yan |
title |
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
title_short |
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
title_full |
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
title_fullStr |
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
title_full_unstemmed |
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
title_sort |
relationship between serum mir-199a-5p and mir-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal |
publisher |
Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases |
publishDate |
2022 |
url |
https://doaj.org/article/4ae03ff196204d588a494b32a035243a |
work_keys_str_mv |
AT guoyan relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal AT zhangkai relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal AT fanxuhui relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal AT lilifeng relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal |
_version_ |
1718413616191897600 |